OPKO HEALTH, INC.

A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.

OPK | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 4400 BISCAYNE BLVD., 33137 MIAMI
Website:: https://www.opko.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company focused on developing and commercializing innovative healthcare solutions. The company operates through two primary segments. Its pharmaceutical division develops novel therapies, with key products including NGENLA™, a long-acting human growth hormone treatment, and RAYALDEE®. The research pipeline focuses on multispecific therapies for cancer and infectious diseases, supported by partnerships with major pharmaceutical organizations. The diagnostics division, through its subsidiary BioReference Laboratories, is one of the largest full-service clinical reference laboratories in the U.S., offering a comprehensive portfolio of testing services to physicians and patients. By integrating its therapeutic and diagnostic capabilities, OPKO aims to establish leading positions in large, growing healthcare markets and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OPKO HEALTH, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPKO HEALTH, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for OPKO HEALTH, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ALK-Abelló Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.	Denmark	ALK
Alkaloid AD Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.	North Macedonia	ALK
Alkermes plc. Develops medicines for CNS disorders like schizophrenia, bipolar, and sleep disorders.	United States of America	ALKS
Allarity Therapeutics, Inc. Develops personalized cancer drugs using a diagnostic platform to predict patient response.	United States of America	ALLR
ALLERGY THERAPEUTICS PLC Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.	United Kingdom	AGY
Alligator Bioscience Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.	Sweden	ATORX
Allogene Therapeutics, Inc. Developing off-the-shelf CAR T-cell therapies for cancer and autoimmune diseases.	United States of America	ALLO
Alma Yesodot Ltd.	Israel	KVSR
Almirall S.A. A global biopharmaceutical company developing innovative medical solutions for skin health.	Spain	ALM
ALNYLAM PHARMACEUTICALS, INC. Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.	United States of America	ALNY